Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma.

To characterize genes that become upregulated with malignant transformation of human hepatocytes, a library of monoclonal antibodies was produced against the FOCUS hepatocellular carcinoma cell line. Antibody FB-50 reacted with an antigen that was highly expressed in 4 of 10 primary hepatocellular carcinomas, in all 20 cholangiocarcinomas we studied, and in a variety of transformed cell lines. This antigen was also highly expressed in neoplastic epithelial cells of breast and colon carcinomas in contrast to its low level of expression in normal hepatocytes and in non-neoplastic epithelial cells. Among the normal adult tissues studied, high levels were observed only in proliferating trophoblastic cells of the placenta and in adrenal glands. A 636-bp partial cDNA, isolated from a gamma GT11 expression library generated with HepG2 human hepatoblastoma cells, and a complete cDNA, generated by reverse transcriptase-PCR, identified the antigen as the human form of aspartyl(asparaginyl)beta-hydroxylase. This enzyme catalyzes posttranslational hydroxylation of beta carbons of specific aspartyl and asparaginyl residues in EGF-like domains of certain proteins. Analyses of extracts prepared from several human tumor cell lines compared to their normal tissue counterparts indicate that the increase in hydroxylase, approximately 10-fold, is controlled at the level of transcription and the protein is expressed in an enzymatically active form. In similar analyses, comparing hepatocellular carcinomas to adjacent uninvolved liver from five patients, enzymatic activity was much higher in the tumor tissue from the four patients whose immunoblots revealed increased hydroxylase protein in the malignant tissue. EGF repeats in the extracellular domain of Notch or its homologs contain the consensus sequence for hydroxylation. Deletion mutants lacking this domain are gain-of-function mutants, suggesting that the domain modulates signal transduction by the cytoplasmic domain. While the function imparted by beta hydroxylation is unknown, our studies raise the possibility that beta hydroxylation is regulated in proteins like the mammalian Notch homologs, whose cytoplasmic domains have been shown to be oncogenic.

[1]  P. Fraker,et al.  PROTEIN AND CELL MEMBRANE IODINATION WITH A SPARINGLY SOLUBLE CHLOROAMIDE , 1978 .

[2]  E. Livanos,et al.  Unique chromosomal rearrangement and mucin production in a novel salivary myoepithelial cell strain. , 1993, Archives of otolaryngology--head & neck surgery.

[3]  K. O. Elliston,et al.  cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase. , 1992, The Journal of biological chemistry.

[4]  J. Wands,et al.  In Vivo expression of two novel tumor‐associated antigens and their use in immunolocalization of human hepatocellular carcinoma , 1989, Hepatology.

[5]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[6]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.

[7]  M. W. Young,et al.  Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei. , 1993, Genes & development.

[8]  V. Garsky,et al.  Bovine liver aspartyl beta-hydroxylase. Purification and characterization. , 1991, The Journal of biological chemistry.

[9]  A. Linstedt,et al.  A novel endocytosis signal related to the KKXX ER‐retrieval signal. , 1995, The EMBO journal.

[10]  H. Weintraub,et al.  Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Fortini,et al.  An activated Notch receptor blocks cell-fate commitment in the developing Drosophila eye , 1993, Nature.

[12]  J. Stenflo,et al.  Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. , 1991, Blood.

[13]  M. Jackson,et al.  An N‐terminal double‐arginine motif maintains type II membrane proteins in the endoplasmic reticulum. , 1994, The EMBO journal.

[14]  T A Rapoport,et al.  Predicting the orientation of eukaryotic membrane-spanning proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Gallahan,et al.  Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. , 1992, Genes & development.

[16]  K. Isselbacher,et al.  Cell-surface changes associated with transformation of human hepatocytes to the malignant phenotype. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Gieffers,et al.  Cloning and characterization of the human gene encoding aspartyl beta-hydroxylase. , 1994, Gene.

[18]  H. Roehl,et al.  Control of cell fate in C. elegans by a GLP-1 peptide consisting primarily of ankyrin repeats , 1993, Nature.

[19]  J. Wands,et al.  Human hepatoma‐associated cell surface antigen: Identification and characterization by means of monoclonal antibodies , 1985, Hepatology.

[20]  J. Sklar,et al.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.

[21]  K. Kivirikko,et al.  Modification of vertebrate and algal prolyl 4-hydroxylases and vertebrate lysyl hydroxylase by diethyl pyrocarbonate. Evidence for histidine residues in the catalytic site of 2-oxoglutarate-coupled dioxygenases. , 1992, The Biochemical journal.

[22]  H. Yamane,et al.  Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6 , 1995, Nature.

[23]  C. Schneider,et al.  The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade , 1993, Molecular and cellular biology.

[24]  J. Devereux,et al.  A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..

[25]  S. Artavanis-Tsakonas,et al.  Cytosolic interaction between deltex and Notch ankyrin repeats implicates deltex in the Notch signaling pathway. , 1994, Development.

[26]  S. Artavanis-Tsakonas,et al.  Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor , 1993, Cell.

[27]  J. Haubrich,et al.  Relationship of cytogenetic subtypes of salivary gland pleomorphic adenomas with patient age and histologic type , 1989, Cancer.

[28]  D. Pinkel,et al.  Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[29]  W. Harris,et al.  Expression of an extracellular deletion of Xotch diverts cell fate in Xenopus embryos , 1993, Cell.

[30]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[31]  B. Dahlbäck,et al.  beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[32]  V. Garsky,et al.  Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  H. Weintraub,et al.  The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. , 1994, Development.

[34]  V. Garsky,et al.  Partial purification and characterization of bovine liver aspartyl beta-hydroxylase. , 1990, The Journal of biological chemistry.

[35]  M. W. Young,et al.  Further evidence for function of the Drosophila Notch protein as a transmembrane receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. O. Elliston,et al.  A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Raphael Kopan,et al.  An activated Notch suppresses neurogenesis and myogenesis but not gliogenesis in mammalian cells. , 1994, Development.

[38]  Pamela F. Jones,et al.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases , 1995, Cell.

[39]  V. Garsky,et al.  Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modules. , 1992, Biochemical and biophysical research communications.

[40]  J. Wands,et al.  Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma. , 1990, Molecular and cellular biology.

[41]  G. Struhl,et al.  Intrinsic activity of the lin-12 and Notch intracellular domains in vivo , 1993, Cell.